Data Analyst: Epigenomes, Cancer, Personal Genomes and/or Rare Diseases

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Job Location
Job Description

A more complete PDF version of this job posting is available from the following URL:

The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna pursue ambitious research projects including large-scale genome/epigenome sequencing of cancer samples, rare disease mapping, and a Personal Genome Project that provides whole genome sequencing to selected volunteers and explores the scientific, educational, ethical, and social implications of genomics. We are now looking for a highly motivated bioinformatic data analyst with experiences in large-scale sequencing analysis to contribute to these efforts.

The Project

Depending on the candidate’s prior experience and interests, the focus of the work could be in one or more of the following areas:

  • Analysis of cancer genome, epigenome, and transcriptome data
  • Bioinformatic methods development for single-cell sequencing technologies
  • Computational prioritization of causal genes in rare Mendelian diseases
  • Contribution to Genom Austria (, which is the Austrian Personal Genome Project


The Biomedical Sequencing Facility []

The successful candidate will be based at the Biomedical Sequencing Facility (BSF) at CeMM, which is headed by Christoph Bock ( The BSF is Austria’s first and leading center of expertise for next generation sequencing in biomedicine, and it performs the genome sequencing and analysis for Genom Austria ( The BSF is equipped with the latest technology for large-scale genome research, including next generation sequencers (Illumina HiSeq and MiSeq technology), 96-well robotic platforms for automated library preparation, dedicated equipment for single-cell analysis, and a powerful scientific computing cluster. The BSF’s mandate includes a strong focus on technology development, contribution to study design and bioinformatic data analysis, as well as training and teaching best practices in high-throughput genomics.


The Institute []

The CeMM Research Center for Molecular Medicine is an international and interdisciplinary research institute of the Austrian Academy of Sciences. Driven by medical needs, CeMM integrates basic research and biomedical expertise to pursue innovative diagnostic and therapeutic approaches focused on cancer, inflammation, and immune disorders. CeMM is located in a new building at the center of Vienna’s Medical University campus, within walking distance of Vienna’s historical city center. According to a recent study by “The Scientist”, CeMM is among the top-5 best places to work in academia world-wide ( Vienna is frequently ranked the world’s best city to live. It is a United Nations city with a large English-speaking community. The official language at CeMM is English, and more than 30 different nationalities are represented at the institute.



The Candidate

We invite applications from candidates who are eager to contribute to the genomics revolution in biomedicine. The ideal candidate has an excellent track record in bioinformatics, human genetics, or a related field (typically including a PhD with or without additional postdoctoral experience although outstanding Master-level applications will also be considered). The exact job description, responsibilities, and salary will be commensurable with experience. All candidates should have prior work experience in world-class institutions. Because CeMM works in highly competitive areas at the forefront of biomedical research, intellectual curiosity, diligence, flexibility, and dedication to science are key success factors.


How to Apply

Please submit cover letter, curriculum vitae, academic transcripts and contact details of three referees to [email protected]. Please indicate the reference code Bioinformatic Data Analyst in the subject line. Applications will be reviewed on a rolling basis, and any application received by 31 January 2015 will be considered.

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.